文献速递肿瘤 PET/CT甲状腺核医学

18F-FDG PET/CT 在生化复发/残留/转移性甲状腺髓样癌中的诊断准确性

Diagnostic Accuracy of 18F-FDG PET/CT in Patients With Biochemical Evidence of Recurrent, Residual, or Metastatic Medullary Thyroid Carcinoma.
PubMed 文献 · Clin Nucl Med · 2019-01-01

该回顾性队列研究纳入45例因降钙素(Ctn)和癌胚抗原(CEA)升高而重新分期的甲状腺髓样癌(MTC)患者,共51次18F-FDG PET/CT检查。以病理为参考标准(不可得时用其他影像和临床随访,平均4年),患者层面分析显示敏感度66.7%、特异度83.3%、阳性预测值88.0%、阴性预测值57.7%、诊断准确性72.5%、阳性似然比4.0。Ctn截断值1000 pg/mL时敏感度升至76.9%;阳性与阴性FDG PET/CT间Ctn和CEA值差异有统计学意义(P<0.05)。

要点

  • FDG PET/CT在MTC生化复发再分期中患者层面敏感度66.7%、特异度83.3%。
  • 阳性预测值88.0%可影响治疗决策,阴性预测值57.7%需严格随访。
  • Ctn截断值1000 pg/mL时敏感度升至76.9%。

核心结论

  • FDG PET/CT可用于MTC生化复发的再分期,在较高Ctn水平时表现更好。
  • 其高阳性预测值(88%)可能影响治疗管理,但低阴性预测值(57.7%)使检查无病理发现时严格随访成为必须。

研究设计与样本

  • 回顾性队列研究,复习45例因随访中Ctn和CEA升高而再分期的MTC患者的51次FDG PET/CT检查。
  • 以病理为参考标准(不可得时用其他影像研究和临床随访,平均4年)进行患者层面诊断准确性分析。

主要发现

  • 25次扫描为阳性。
  • 敏感度66.7%、特异度83.3%、阳性预测值88.0%、阴性预测值57.7%、诊断准确性72.5%、阳性似然比4.0。
  • 使用Ctn截断值1000 pg/mL时,敏感度增至76.9%。
  • 阳性与阴性FDG PET/CT间的Ctn和CEA值差异有统计学意义(P<0.05)。
  • 在真阳性研究中,比较局部区域与转移性疾病的平均SUVmax处于显著性边缘(P=0.046)。

关键数值与推荐

  • 患者层面敏感度66.7%、特异度83.3%、阳性预测值88.0%、阴性预测值57.7%、诊断准确性72.5%、阳性似然比4.0。
  • Ctn截断值1000 pg/mL时敏感度76.9%。
  • 阳性与阴性FDG PET/CT间Ctn和CEA值差异P<0.05。
  • 真阳性研究中局部区域与转移性疾病平均SUVmax比较P=0.046。

临床怎么用

  • 对生化复发MTC患者可行FDG PET/CT再分期,尤其Ctn水平较高时。
  • 阳性结果(阳性预测值88%)可支持治疗决策调整。
  • 阴性结果(阴性预测值57.7%)不能排除病灶,需严格临床随访。

局限性

  • 回顾性队列研究设计。
  • 参考标准不完全统一:病理不可得时使用其他影像和临床随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Medullary thyroid carcinoma (MTC) is a rare malignancy. Location of residual, recurrent, or metastatic disease is crucial to treatment management and outcome. We aimed to evaluate the use of F-FDG PET/CT in localizing MTC foci in patients with biochemical relapse. METHODS: This is a retrospective cohort study. Review of 51 FDG PET/CT studies of 45 patients referred to restage MTC due to increased calcitonin (Ctn) and carcinoembryonic antigen (CEA) values at follow-up. FDG PET/CT diagnostic accuracy was determined through a patient-based analysis, using histology as criterion standard when available, or other imaging studies and clinical follow-up otherwise (mean, 4 years). RESULTS: There were 25 positive scans. Sensitivity, specificity, positive and negative predictive values, diagnostic accuracy, and positive likelihood ratio were 66.7%, 83.3%, 88.0%, 57.7%, 72.5%, and 4.0, respectively. Using a Ctn cutoff of 1000 pg/mL, sensitivity increased to 76.9%. There were significant differences of Ctn and CEA values between positive and negative FDG PET/CT (P < 0.05). Regarding true-positive studies, average SUVmax comparing locoregional and metastatic disease was at the limit of significance (P = 0.046). CONCLUSIONS: PET/CT can be useful to restage patients with biochemical relapse of MTC, with a better performance in higher Ctn levels. Its high positive predictive value (88%) may impact in the therapeutic management, although its low negative predictive value (57.7%) makes strict follow-up mandatory in examinations without pathologic findings.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Bel L, Sabaté-Llobera A, Rossi-Seoane S, et al. Diagnostic Accuracy of 18F-FDG PET/CT in Patients With Biochemical Evidence of Recurrent, Residual, or Metastatic Medullary Thyroid Carcinoma. Clin Nucl Med. 2019. PMID: 30562193. doi:10.1097/RLU.0000000000002414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。